Thakur Nutan, Jain Swapnil, Changotra Harish, Shrivastava Rahul, Kumar Yashwant, Grover Neelam, Vashistt Jitendraa
Department of Biotechnology & Bioinformatics, Jaypee University of Information Technology, Solan, India.
National Salmonella & Escherichia coli Centre, Central Research Institute, Kasauli, India.
J Clin Lab Anal. 2018 Jun;32(5):e22388. doi: 10.1002/jcla.22388. Epub 2018 Jan 21.
Diarrheagenic Escherichia coli (DEC) signifies as an important etiological agent of moderate-to-severe diarrhea. This study was primarily focused on molecular identification of DEC pathotypes; their association with serogroups and estimates of resistance profiles against different antibiotics regime.
Five hundred seventy-two stool specimens from diarrhea patients were investigated for DEC pathotypes. Molecular pathotypes were identified by amplification of virulence genes associated with distinct pathotypes followed by sequencing. Diarrhea is a self-limiting disease, however, severity and persistence of infection suggest antibiotic use. Therefore, AST and MIC were determined against common antibiotic regimen. Correlations between molecular pathotypes and serogroups were analyzed by somatic "O" antigen serotyping.
The present findings reveal incidence of DEC as an etiological agent up to a level of 21% among all diarrheal age groups. DEC infection rate was higher in children. Enteropathogenic E. coliEPEC, a molecular pathotype of DEC, was found as a predominant pathotype with highest frequency of 13.7%. Two other molecular pathotypes enterotoxigenic E. coli (ETEC) and enteroaggregative E. coli (EAEC) accounted for 5.7% and 1.3%, respectively for all diarrhea incidences. Serological analysis deciphered somatic antigens O26, O2, and O3 as major serogroups identified among EPEC, ETEC, and EAEC pathotypes, respectively. All DEC pathotypes exhibited high levels of antibiotic resistance except for cotrimoxazole and norfloxacin.
Comprehensive molecular characterization of DEC pathotypes, their incidence estimates, and antibiogram patterns will help in ascertaining better diagnostic and therapeutic measures in management of diarrheal diseases.
致泻性大肠杆菌(DEC)是中重度腹泻的重要病原体。本研究主要聚焦于DEC致病型的分子鉴定;它们与血清群的关联以及对不同抗生素方案的耐药性评估。
对572份腹泻患者的粪便标本进行DEC致病型调查。通过扩增与不同致病型相关的毒力基因并测序来鉴定分子致病型。腹泻是一种自限性疾病,然而,感染的严重程度和持续性表明需要使用抗生素。因此,针对常见抗生素方案测定了药敏试验(AST)和最低抑菌浓度(MIC)。通过菌体“O”抗原血清分型分析分子致病型与血清群之间的相关性。
目前的研究结果显示,在所有腹泻年龄组中,DEC作为病原体的发生率高达21%。儿童的DEC感染率更高。DEC的一种分子致病型肠致病性大肠杆菌(EPEC)是主要致病型,频率最高,为13.7%。另外两种分子致病型产肠毒素大肠杆菌(ETEC)和肠集聚性大肠杆菌(EAEC)在所有腹泻病例中的占比分别为5.7%和1.3%。血清学分析分别在EPEC、ETEC和EAEC致病型中鉴定出菌体抗原O26、O2和O3为主要血清群。除复方新诺明和诺氟沙星外,所有DEC致病型均表现出高水平的抗生素耐药性。
对DEC致病型进行全面的分子特征分析、发生率评估和抗菌谱模式分析,将有助于确定更好的腹泻病诊断和治疗措施。